Systemic sclerosis manifestations and clinical outcomes in Hispanics/Latinos of the American Southwest.
Sharon E NunezAngie Ariza-HutchinsonRoderick A FieldsJaime A VondenbergRosemina A PatelN Suzanne EmilMaheswari MuruganandamJames I GibbJanet L PooleWilmer L SibbittPublished in: Journal of scleroderma and related disorders (2022)
Systemic sclerosis phenotype, autoantibodies, complications, outcomes, malignancy rates, and mortality are generally similar between Hispanics and non-Hispanics with systemic sclerosis in the American Southwest. However, age-adjusted comorbid malignancy and mortality rates are significantly increased in both groups.